Page last updated: 2024-08-26

combretastatin and Angiogenesis, Pathologic

combretastatin has been researched along with Angiogenesis, Pathologic in 29 studies

Research

Studies (29)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's11 (37.93)29.6817
2010's17 (58.62)24.3611
2020's1 (3.45)2.80

Authors

AuthorsStudies
Elming, PB; Horsman, MR; Nielsen, PS; Wittenborn, TR1
Aoshima, K; Hoshino, Y; Izumi, Y; Takagi, S1
Sherbet, GV1
Horsman, MR1
Bertelsen, LB; Busk, M; Bussink, J; Horsman, MR; Iversen, AB; Laustsen, C; Lok, J; Munk, OL; Nielsen, T; Stødkilde-Jørgensen, H; Wittenborn, TR1
Izumi, Y; Takagi, S1
Azzariti, A; Gnoni, A; Numico, G; Paradiso, A; Porcelli, L; Quatrale, AE1
Bertelsen, LB; Bohn, AB; Brems-Eskildsen, AS; Horsman, MR; Laurberg, T; Møller, BK; Nielsen, T; Stødkilde-Jørgensen, H; Wittenborn, T1
Chen, Z; Deng, C; Feng, L; Li, C; Long, Y; Su, T; Zhang, X1
Abma, E; Daminet, S; de Rooster, H; Ni, Y; Smets, P1
Basso, G; Bortolozzi, R; Mitola, S; Porcù, E; Primac, I; Ravelli, C; Romagnoli, R; Ronca, R; Salvador, A; Vedaldi, D; Viola, G1
Bueno, O; Canela, MD; Liekens, S; Martins, MS; Pérez-Pérez, MJ; Priego, EM1
Gevertz, JL1
Burchill, SA; Dalal, S1
Kanthou, C; Tozer, GM1
Cai, YC; Xian, LJ; Zou, Y1
Haselwandter, CA; Kardar, M; Kohandel, M; Sengupta, S; Sivaloganathan, S1
Lenihan, DJ; Subbiah, IM; Tsimberidou, AM1
Barsoum, J; Borella, C; Foley, KP; Jiang, J; Korbut, T; Li, H; Sang, J; Sonderfan, AJ; Wu, Y; Ye, J; Zhang, M; Zhang, X; Zhou, D1
Gore, M; Gourley, C; Hall, M; Jayson, G; Kaye, S; Ledermann, J; McNeish, I; Perren, T; Rustin, G1
Mariani, SM1
Kiziltepe, T; Sasisekharan, R; Sengupta, S1
Baguley, BC; Kanthou, C; Tozer, GM1
Mooney, D1
Capila, I; Eavarone, D; Kiziltepe, T; Sasisekharan, R; Sengupta, S; Watson, N; Zhao, G1
Bajenaru, ML; Feuer, W; Fini, ME; Jockovich, ME; Murray, TG; Piña, Y; Suarez, F1
Randal, J1
Bailly, C; Lansiaux, A; Verdier-Pinard, P1
Hill, SA; Kanthou, C; Parkins, CS; Tozer, GM1

Reviews

9 review(s) available for combretastatin and Angiogenesis, Pathologic

ArticleYear
Suppression of angiogenesis and tumour progression by combretastatin and derivatives.
    Cancer letters, 2017, 09-10, Volume: 403

    Topics: Angiogenesis Inhibitors; Animals; Bibenzyls; Cell Movement; Cell Proliferation; Disease Progression; Epithelial-Mesenchymal Transition; Humans; Neoplasm Invasiveness; Neoplasms; Neovascularization, Pathologic; Signal Transduction; Tumor Burden

2017
New vascular disrupting agents in upper gastrointestinal malignancies.
    Current medicinal chemistry, 2014, Volume: 21, Issue:8

    Topics: Angiogenesis Inhibitors; Animals; Bibenzyls; Diphosphates; Gastrointestinal Neoplasms; Humans; Neovascularization, Pathologic; Organophosphorus Compounds; Serine; Stilbenes; Upper Gastrointestinal Tract

2014
Combretastatin A4-phosphate and its potential in veterinary oncology: a review.
    Veterinary and comparative oncology, 2017, Volume: 15, Issue:1

    Topics: Animals; Antineoplastic Agents, Phytogenic; Bibenzyls; Dog Diseases; Dogs; Humans; Medical Oncology; Mice; Neoplasms; Neovascularization, Pathologic; Veterinary Medicine

2017
Microtubule depolymerizing vascular disrupting agents: novel therapeutic agents for oncology and other pathologies.
    International journal of experimental pathology, 2009, Volume: 90, Issue:3

    Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Bibenzyls; Drug Resistance, Neoplasm; Humans; Neoplasms; Neovascularization, Pathologic; Tubulin Modulators

2009
[Advances in the study of the anti-tumor activity of small molecule vascular disrupting agents].
    Yao xue xue bao = Acta pharmaceutica Sinica, 2010, Volume: 45, Issue:3

    Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Bibenzyls; Diphosphates; Endothelial Cells; Humans; Molecular Structure; Neoplasms; Neovascularization, Pathologic; Oligopeptides; Organophosphorus Compounds; Serine; Stilbenes; Tubulin Modulators; Xanthones

2010
Targeted anti-vascular therapies for ovarian cancer: current evidence.
    British journal of cancer, 2013, Feb-05, Volume: 108, Issue:2

    Topics: Angiogenesis Inhibitors; Angiopoietins; Angiostatins; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Bibenzyls; Female; Fibroblast Growth Factors; Flavonoids; Humans; Molecular Targeted Therapy; Neovascularization, Pathologic; Ovarian Neoplasms; Thrombospondins; Treatment Outcome; Vascular Endothelial Growth Factors

2013
Disrupting tumour blood vessels.
    Nature reviews. Cancer, 2005, Volume: 5, Issue:6

    Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Bibenzyls; Capillary Permeability; Clinical Trials as Topic; Endothelial Cells; Humans; Neoplasms; Neovascularization, Pathologic; Stilbenes; Xanthones

2005
[Combretastatin A4 phosphate].
    Bulletin du cancer, 2001, Volume: 88, Issue:3

    Topics: Animals; Antineoplastic Agents, Phytogenic; Bibenzyls; Clinical Trials as Topic; Drug Evaluation, Preclinical; Humans; Mice; Neoplasms; Neovascularization, Pathologic; Quantitative Structure-Activity Relationship; Rats; Stilbenes; Transplantation, Heterologous

2001
The biology of the combretastatins as tumour vascular targeting agents.
    International journal of experimental pathology, 2002, Volume: 83, Issue:1

    Topics: Animals; Antineoplastic Agents, Phytogenic; Bibenzyls; Endothelium, Vascular; Humans; Neoplasms; Neovascularization, Pathologic; Stilbenes

2002

Other Studies

20 other study(ies) available for combretastatin and Angiogenesis, Pathologic

ArticleYear
Tumors Resistant to Checkpoint Inhibitors Can Become Sensitive after Treatment with Vascular Disrupting Agents.
    International journal of molecular sciences, 2020, Jul-06, Volume: 21, Issue:13

    Topics: Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; B7-H1 Antigen; Bibenzyls; CTLA-4 Antigen; Diphosphates; Disease Progression; Drug Resistance, Neoplasm; Female; Immune Checkpoint Inhibitors; Male; Mammary Neoplasms, Animal; Mice; Mice, Inbred C3H; Neovascularization, Pathologic; Stilbenes; Treatment Outcome

2020
Effects of combretastatin A-4 phosphate on canine normal and tumor tissue-derived endothelial cells.
    Research in veterinary science, 2017, Volume: 112

    Topics: Animals; Bibenzyls; Cells, Cultured; Dogs; Endothelial Cells; Endothelium, Vascular; Humans; Neoplasms; Neovascularization, Pathologic; Phosphates; Stilbenes

2017
Enhancing the radiation response of tumors but not early or late responding normal tissues using a vascular disrupting agent.
    Acta oncologica (Stockholm, Sweden), 2017, Volume: 56, Issue:11

    Topics: Animals; Antineoplastic Agents, Phytogenic; Bibenzyls; Female; Gamma Rays; Lung; Mammary Neoplasms, Animal; Mice; Mice, Inbred C3H; Neovascularization, Pathologic; Radiation-Sensitizing Agents; Skin; Urinary Bladder

2017
The potential of hyperpolarized
    Acta oncologica (Stockholm, Sweden), 2017, Volume: 56, Issue:11

    Topics: Animals; Antineoplastic Agents, Phytogenic; Bibenzyls; Carbon Isotopes; Female; Magnetic Resonance Spectroscopy; Mammary Neoplasms, Animal; Mice; Mice, Inbred C3H; Neovascularization, Pathologic; Positron-Emission Tomography; Tissue Distribution

2017
Vascular disrupting effect of combretastatin A-4 phosphate with inhibition of vascular endothelial cadherin in canine osteosarcoma-xenografted mice.
    Research in veterinary science, 2019, Volume: 122

    Topics: Animals; Antigens, CD; Bibenzyls; Cadherins; Dog Diseases; Dogs; Endothelium, Vascular; Gene Expression Regulation, Neoplastic; Heterografts; Humans; Mice; Neoplasms, Experimental; Neovascularization, Pathologic; Osteosarcoma

2019
A combretastatin-mediated decrease in neutrophil concentration in peripheral blood and the impact on the anti-tumor activity of this drug in two different murine tumor models.
    PloS one, 2014, Volume: 9, Issue:10

    Topics: Animals; Bibenzyls; Carcinoma, Squamous Cell; Disease Models, Animal; Female; Flow Cytometry; Granulocytes; Humans; Mammary Neoplasms, Animal; Mice; Necrosis; Neovascularization, Pathologic; Neutrophils

2014
Construction of a two-in-one liposomal system (TWOLips) for tumor-targeted combination therapy.
    International journal of pharmaceutics, 2014, Dec-10, Volume: 476, Issue:1-2

    Topics: Animals; Antineoplastic Agents; Bibenzyls; Doxorubicin; Drug Combinations; Drug Delivery Systems; Drug Stability; Drug Storage; Female; Humans; Liposomes; Male; Melanoma; Mice; Mice, Inbred BALB C; Mice, Nude; Neovascularization, Pathologic; Particle Size; Silicon Dioxide; Survival Rate; Xenograft Model Antitumor Assays

2014
Vascular disrupting activity of combretastatin analogues.
    Vascular pharmacology, 2016, Volume: 83

    Topics: Angiogenesis Inducing Agents; Angiogenesis Inhibitors; Animals; Antigens, CD; Bibenzyls; Cadherins; Capillary Permeability; Cardiac Myosins; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Shape; Cells, Cultured; Chick Embryo; Chorioallantoic Membrane; Dose-Response Relationship, Drug; Focal Adhesion Kinase 1; Human Umbilical Vein Endothelial Cells; Humans; Melanoma, Experimental; Mice, Inbred C57BL; Myosin Light Chains; Neovascularization, Pathologic; Neovascularization, Physiologic; Phosphorylation; Signal Transduction; Time Factors

2016
Blocking Blood Flow to Solid Tumors by Destabilizing Tubulin: An Approach to Targeting Tumor Growth.
    Journal of medicinal chemistry, 2016, 10-13, Volume: 59, Issue:19

    Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Phytogenic; Bibenzyls; Drug Discovery; Hemodynamics; Humans; Models, Molecular; Neoplasms; Neovascularization, Pathologic; Tubulin; Tubulin Modulators

2016
Microenvironment-Mediated Modeling of Tumor Response to Vascular-Targeting Drugs.
    Advances in experimental medicine and biology, 2016, Volume: 936

    Topics: Angiogenesis Inhibitors; Bevacizumab; Bibenzyls; Computer Simulation; Cytotoxins; Drug Combinations; Drug Dosage Calculations; Endothelial Cells; Everolimus; Humans; Models, Statistical; Neoplasms; Neovascularization, Pathologic; Tumor Microenvironment; Xanthones

2016
Preclinical evaluation of vascular-disrupting agents in Ewing's sarcoma family of tumours.
    European journal of cancer (Oxford, England : 1990), 2009, Volume: 45, Issue:4

    Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bibenzyls; Bone Neoplasms; Cell Proliferation; Diphosphates; Disease Models, Animal; Doxorubicin; Drug Evaluation, Preclinical; Mice; Mice, Nude; Necrosis; Neoplasm Transplantation; Neovascularization, Pathologic; Sarcoma, Ewing; Stilbenes

2009
Quantitative model for efficient temporal targeting of tumor cells and neovasculature.
    Computational and mathematical methods in medicine, 2011, Volume: 2011

    Topics: Algorithms; Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bibenzyls; Biological Availability; Carcinoma, Lewis Lung; Computer Simulation; Doxorubicin; Drug Delivery Systems; Drug Synergism; Liposomes; Melanoma, Experimental; Mice; Models, Biological; Nanoparticles; Neoplasms; Neovascularization, Pathologic; Time Factors; Treatment Outcome

2011
Cardiovascular toxicity profiles of vascular-disrupting agents.
    The oncologist, 2011, Volume: 16, Issue:8

    Topics: Angiogenesis Inhibitors; Bibenzyls; Cardiovascular System; Clinical Trials as Topic; Humans; Neoplasms; Neovascularization, Pathologic; Organophosphorus Compounds; Quinazolines; Serine; Xanthones

2011
The vascular disrupting agent STA-9584 exhibits potent antitumor activity by selectively targeting microvasculature at both the center and periphery of tumors.
    The Journal of pharmacology and experimental therapeutics, 2012, Volume: 343, Issue:2

    Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Bibenzyls; Cell Survival; Dogs; Female; Heart; Hemodynamics; Human Umbilical Vein Endothelial Cells; Humans; In Vitro Techniques; Isoxazoles; Male; Mice; Mice, Inbred BALB C; Mice, SCID; Microcirculation; Neoplasms; Neovascularization, Pathologic; Phenylalanine; Rabbits; Regional Blood Flow; Tubulin Modulators; Xenograft Model Antitumor Assays

2012
Anti-angiogenesis: the challenges ahead.
    MedGenMed : Medscape general medicine, 2003, Apr-30, Volume: 5, Issue:2

    Topics: Angiogenesis Inhibitors; Angiogenic Proteins; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Phytogenic; Bevacizumab; Bibenzyls; Biological Availability; Biomarkers; Carcinoma, Renal Cell; Clinical Trials as Topic; Combined Modality Therapy; Drug Resistance, Neoplasm; Endostatins; Endothelial Growth Factors; Endothelium, Vascular; Growth Inhibitors; Humans; Kidney Neoplasms; Microtubules; Neoplasms; Neovascularization, Pathologic; Ontario; Receptors, Vascular Endothelial Growth Factor; Stilbenes

2003
A dual-color fluorescence imaging-based system for the dissection of antiangiogenic and chemotherapeutic activity of molecules.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2004, Volume: 18, Issue:13

    Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Bibenzyls; Cell Line, Tumor; Coculture Techniques; Doxorubicin; Extracellular Matrix; Fluorescence; Hepatocyte Growth Factor; Humans; Melanoma; Neoplasms; Neovascularization, Pathologic; Phthalazines; Pyridines; Stilbenes; Thalidomide; Vascular Endothelial Growth Factor A

2004
Cancer: one step at a time.
    Nature, 2005, Jul-28, Volume: 436, Issue:7050

    Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Bibenzyls; Doxorubicin; Drug Delivery Systems; Drug Therapy, Combination; Humans; Mice; Nanotechnology; Neoplasms; Neovascularization, Pathologic; Stilbenes; Time Factors

2005
Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system.
    Nature, 2005, Jul-28, Volume: 436, Issue:7050

    Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Bibenzyls; Carcinoma, Lewis Lung; Coculture Techniques; Doxorubicin; Drug Delivery Systems; Drug Therapy, Combination; Endothelial Cells; Humans; Melanoma, Experimental; Mice; Nanotechnology; Neoplasms; Neovascularization, Pathologic; Stilbenes; Time Factors; Tissue Distribution

2005
Retinoblastoma tumor vessel maturation impacts efficacy of vessel targeting in the LH(BETA)T(AG) mouse model.
    Investigative ophthalmology & visual science, 2007, Volume: 48, Issue:6

    Topics: Actins; Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Phytogenic; Bibenzyls; Biomarkers, Tumor; Cell Proliferation; Disease Models, Animal; Endoglin; Endothelium, Vascular; Intracellular Signaling Peptides and Proteins; Ki-67 Antigen; Mice; Mice, Transgenic; Microscopy, Fluorescence; Neovascularization, Pathologic; Pericytes; Pregnadienediols; Retinal Neoplasms; Retinoblastoma; Stilbenes

2007
Antiangiogenesis drugs target specific cancers, mechanisms.
    Journal of the National Cancer Institute, 2000, Apr-05, Volume: 92, Issue:7

    Topics: Angiostatins; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Bibenzyls; Humans; Matrix Metalloproteinase Inhibitors; Neoplasms; Neovascularization, Pathologic; Peptide Fragments; Plasminogen; Stilbenes

2000